Home Multimedia Podcasts

Multimedia Podcasts

Attention: open in a new window. PDFPrint


 Chagas is global: Manuel Gutiérrez Torrico tells the creation of FINDECHAGAS  [April 21, 2012]
 


Interview of Manuel Gutiérrez Torrico, former President of FINDECHAGAS.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

 FindeChagas : Chagas Day  [April 14, 2012]
 


Interview of Eric Stobbaerts, Head of Regional Office, DNDi Latin Americai.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

 Argentina launches benznidazole  [April 4, 2012]
 


Interview of Bernard Pécoul, DNDi Executive Director (March 20, 2012)i.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

 Drug development pipeline for Human African Trypanosomiasis (HAT)  [March 12, 2012]
 


Interview of Dr. Nahtalie Strub Wourgaft, Medical Director at DNDi.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

Registration of paramomycin in Uganda (VL)  [March 12, 2012]
 


Interview of Dr. Joseph Olobo, Associate Professor, Makerere University, Uganda.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

Professor El Hassan on DNDi and the LEAP platform’s efforts to strengthen Sudan’s capacity to combat VL

 [January 30, 2012] 

 

Professor El Hassan from the Institute of Endemic Diseases, University of Khartoum, explains how DNDi and the LEAP platform have endeavoured over nearly a decade to bring change through capacity strengthening to the management and treatment of VL in Sudan

JavaScript is disabled!
To display this content, you need a JavaScript capable browser.

To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts


Major Project launched to Support India and Bangladesh's National Control Programmes in Implementing New Treatments to Boost Kala-Azar Elimination Strategies [November 07, 2011] 
 

 Interview with consortium partners: Dr. Bhawna Sharma (Head of DNDi India), Sally Ellis (Clinical Manager, DNDi), Dr. Philippe Desjeux (Senior Programme Officer, OWH), and Dr. Byron Arana (Scientist, TDR)

 

JavaScript is disabled!
To display this content, you need a JavaScript capable browser.

To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

DNDi collaborates closely with neglected disease-endemic countries [November 07, 2011]
 

Carlos Morel, Director of the Centre for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil, gives his perspective on DNDi's specificities as an organization embedded in neglected disease-endemic countries.

JavaScript is disabled!
To display this content, you need a JavaScript capable browser.

To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

Leishmaniasis East Africa Platform (LEAP) creating change for clinical researchers  [September 30, 2011]
 


Dr Monique Wasunna, Head of DNDi Africa, and participants in the Good Clinical Practice (GCP) training course, Nairobi, Kenya (September 2011) talk about LEAP and the impact of capacity building.



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

 
The expansion of DNDi's portfolio into paediatric HIV and helminth infections
 [July 18, 2011]
 
Bernard Pécoul, Executive Director of DNDi, speaks about the expansion of DNDi’s portfolio into paediatric HIV and helminth infections. 



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts

 
DNDi launches new drugs development programmes to address treatment needs of children with HIV/AIDS [July 18, 2011]
  
Marc Lallemant, Head of HIV Programme, speaks about paediatric HIV and DNDi's strategy for paediatric HIV. 

puce Who are you Marc Lallemant?



puce Modes of transmission of paediatric HIV/AIDS



puce Current treatments and their limitations for paediatric HIV



puce DNDi's portfolio expansion to paediatric HIV



puce DNDi's strategy for paediatric HIV



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts
 

New potential oral drug for sleeping sickness
[28 June 2011]
  
Bernard Pécoul, Executive Director of DNDi, speaks about DNDi and the biotech partnership with Anacor and SCYNEXIS for a new potential oral treatment for sleeping sickness at a press conference in Washington DC



To subscribe to DNDi Podcasts, click here: http://feeds.feedburner.com/dndipodcasts


Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License